Evidence map›Paper›PMID 24797482›Full record

ArticleScience (New York, N.Y.)2014

Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors.

Lida Katsimpardi, Nadia K Litterman, Pamela A Schein, Christine M Miller, Francesco S Loffredo, Gregory R Wojtkiewicz, John W Chen, Richard T Lee, Amy J Wagers, Lee L Rubin

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 603 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
603citing papers in PubMed, 1 pooled it
45.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02460731 phase1completednot on this mapstarted 2015, after this paper: background citation

A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy

TypeinterventionalSponsorUniversity of California, San FranciscoRan2015 to 2019Enrolled6ConditionsProgressive Supranuclear PalsyArmsFresh Frozen Plasma
NCT03353597 phase1 / phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects

TypeinterventionalSponsorChandra DuggiralaRan2018 to 2022Enrolled2,120ConditionsAgingArmsPlasma Transfusion
NCT04241159 early_phase1withdrawnnot on this mapstarted 2020, after this paper: background citation

A Small-Scale Study to Explore the Safety and Feasibility of Allogeneic Young Plasma Infusion in Older Adults Experiencing Disability Across the Spectrum of Frailty Syndrome

TypeinterventionalSponsorWake Forest University Health SciencesRan2020 to 2020Enrolled0ConditionsFrailty Syndrome, Heart FailureArmsAllogeneic Young Plasma
3 · Its place in the literature

Who cites it

603 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,029 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Aged circulating CD8Immunity · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. [Growth differentiation factor 11 attenuates hypoxia/reoxygenation injury in rat H9C2 cardiomyocytesNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  20. Article

543 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lida KatsimpardiDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
Nadia K Litterman
Pamela A Schein
Christine M Miller
Francesco S Loffredo
Gregory R Wojtkiewicz
John W Chen
Richard T Lee
Amy J Wagers
Lee L Rubin
Harvard Stem Cell Institute · USHarvard University · US

Funding

Microenvironmental control of progenitors in organ dysfunction and repairU01HL100402 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KIM, CARLA F., SCADDEN, DAVID T · 2009 to 2015
$8.5M
Aging and Rejuvenation of the hematopoietic stem cell nicheDP2OD004345 · OD · JOSLIN DIABETES CENTER · PI WAGERS, AMY JO · 2008 to 2008
$2.4M
Reversing age-related dysfunction of skeletal muscle stem cellsR01AG033053 · NIA · JOSLIN DIABETES CENTER · PI WAGERS, AMY JO · 2009 to 2014
$2.0M
Aging and Myocardial Progenitor RecruitmentR01AG032977 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, RICHARD T · 2009 to 2013
$1.9M
Myeloperoxidase, imaging biomarker and treatment target for multiple sclerosisR01NS070835 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CHEN, JOHN W · 2010 to 2014
$1.9M
Cardiomyocyte Lineage and Turnover by Metabolic Fate-MappingR01AG040019 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, RICHARD T · 2011 to 2015
$1.9M
Imaging and Treating Inflammation in Stroke by Targeting MyeloperoxidaseR01NS072167 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CHEN, JOHN W · 2010 to 2014
$1.8M
Howard Hughes Medical InstituteNHLBI NIH HHS 5U01 HL100402NHLBI NIH HHS U01 HL100402NIA NIH HHS 1R01 AG033053NIA NIH HHS 1R01 AG040019NIA NIH HHS R01 AG032977NIA NIH HHS R01 AG033053NIA NIH HHS R01 AG040019NIH HHS 1DP2 OD004345NIH HHS DP2 OD004345NINDS NIH HHS R01 NS070835NINDS NIH HHS R01NS070835NINDS NIH HHS R01 NS072167NINDS NIH HHS R01NS072167
6 · The paper itself

Abstract

In the adult central nervous system, the vasculature of the neurogenic niche regulates neural stem cell behavior by providing circulating and secreted factors. Age-related decline of neurogenesis and cognitive function is associated with reduced blood flow and decreased numbers of neural stem cells. Therefore, restoring the functionality of the niche should counteract some of the negative effects of aging. We show that factors found in young blood induce vascular remodeling, culminating in increased neurogenesis and improved olfactory discrimination in aging mice. Further, we show that GDF11 alone can improve the cerebral vasculature and enhance neurogenesis. The identification of factors that slow the age-dependent deterioration of the neurogenic niche in mice may constitute the basis for new methods of treating age-related neurodegenerative and neurovascular diseases.

Indexed as

RejuvenationAgingAnimalsBone Morphogenetic ProteinsBrainCerebrovascular CirculationCognitionEndothelium, VascularGrowth Differentiation FactorsMaleMiceMice, Inbred C57BLNeural Stem CellsNeurogenesisOlfactory BulbParabiosisBone Morphogenetic ProteinsGdf11 protein, mouseGrowth Differentiation FactorsRecombinant Proteins

Identifiers

PMID24797482
PMCPMC4123747
OpenAlexW2067028731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.